48Hour Discovery shows exceptional innovation, growth, management, and societal impact, according to BestStartup.
Category: Network News
The collaborative project is partnered with CQDM, Simon Fraser University, Amgen, Merck, and Servier.
A GlycoCage technology developed by GlycoNet researchers aims to improve current treatments for inflammatory bowel disease
Scientific collaboration yields new hope for children affected by rare blood disorder
Dr. Yves St-Pierre shared how glycomics could help develop a new-generation cancer immunotherapy.
Trainees will receive support and resources while advancing glycomics research in areas such as antimicrobials, drug discovery, immune response, cancer, and neurodegenerative diseases
From offering policy advice to sharing his expertise on COVID-19 with the media and public, Dr. Donald Sheppard is recognized a role model with his achievement in engaging with the broader community
Genetic disease research has benefitted substantially from the study of glycomics, which relates to the functions of glycans, or sugar, in biological systems
Research highlights potential pathway for new treatments for neurodegenerative diseases
Dr. Mike Riddell has spent his career looking at ways to make diabetes easier and safer for those who are living with it. He talks about the why and how behind it.